TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2005

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.

William Kevin Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.